Galderma Group N (GALD.SW)
CHF 96.0
(1.12%)
CHF 96.0
(1.12%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | 139.11 Million | 106.29 Million | 178.92 Million |
| Net Income | -48.1 Million | -92.54 Million | -75.24 Million |
| Depreciation & Amortization | 232.47 Million | 265.22 Million | 228.1 Million |
| Deferred income taxes | -2.87 Million | 38.77 Million | 56.31 Million |
| Stock-based compensation | - | - | - |
| Change in working capital | 26.4 Million | -74.97 Million | 23.4 Million |
| Other non-cash items | -71.66 Million | 546.2 Million | 342.66 Million |
| Investing Cash Flow | -146.09 Million | -70.48 Million | -487.76 Million |
| Investments in PPE | -102.02 Million | -152.33 Million | -117.02 Million |
| Acquisitions | -21.02 Million | 81.84 Million | -363.42 Million |
| Investment purchases | - | - | -7.31 Million |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -23.04 Million | 32.45 Million | -78.54 Million |
| Financing Cash Flow | 119.18 Million | -68.86 Million | 290 Million |
| Debt repayment | -731.48 Million | -68.86 Million | -290 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 908.89 Million | - | - |
| Other Financing Activities | 850.66 Million | -6.74 Million | -9.76 Million |
| Accounts receivables | 39.69 Million | -63.89 Million | -33.73 Million |
| Accounts payables | -58.95 Million | 139.63 Million | 141.89 Million |
| Inventory | 26.15 Million | -121.67 Million | -48.27 Million |
| Other working capital | -39.44 Million | -29.03 Million | -36.47 Million |
| Cash at beginning of period | 216.44 Million | 259.22 Million | 278.05 Million |
| Cash at end of period | 309.34 Million | 216.4 Million | 259.22 Million |
| Capital Expenditure | -102.02 Million | -152.33 Million | -117.02 Million |
| Effect of forex changes on cash | 252.32 Thousand | -23.02 Million | -15.05 Million |
| Net cash flow / Change in cash | 92.9 Million | -42.81 Million | -18.83 Million |
| Free Cash Flow | 37.09 Million | -46.03 Million | 61.89 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 21.11 Million | 21.19 Million | -51.4 Million | -54.18 Million | 3.64 Million | 1.82 Million |
| Depreciation & Amortization | 63.78 Million | 53.66 Million | 248.38 Million | 127.84 Million | 120.39 Million | 52.14 Million |
| Deferred income taxes | - | - | -2.87 Million | -2.83 Million | - | - |
| Stock-based compensation | 20.66 Million | 20.74 Million | - | - | - | - |
| Change in working capital | -86.68 Million | -87.03 Million | -30.64 Million | 202.38 Million | -232.57 Million | -88.73 Million |
| Other non-cash items | 20.66 Million | 31.11 Million | 470.53 Million | 108.55 Million | 358.43 Million | -41.16 Million |
| Investing Cash Flow | -80.84 Million | -81.16 Million | -156.09 Million | -59.84 Million | -93.94 Million | -47.11 Million |
| Investments in PPE | -13.47 Million | -13.52 Million | -137.31 Million | -64.14 Million | -71.14 Million | -13.26 Million |
| Acquisitions | -22.45 Million | -22.54 Million | -19.32 Million | 3.76 Million | -22.8 Million | -11.43 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -44.91 Million | -45.09 Million | 539.19 Thousand | 531.21 Thousand | -21.92 Million | -22.41 Million |
| Financing Cash Flow | 55.24 Million | 55.46 Million | 127.33 Million | -137.21 Million | 262.67 Million | 131.72 Million |
| Debt repayment | -1.78 Billion | - | -781.55 Million | -359.57 Million | -410.42 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.92 Billion | - | 908.89 Million | 221.44 Million | 674 Million | - |
| Other Financing Activities | 55.24 Million | 55.46 Million | 850.66 Million | - | 128.88 Million | 131.72 Million |
| Accounts receivables | -90.73 Million | -91.08 Million | 42.41 Million | 102.89 Million | -61.1 Million | -30.64 Million |
| Accounts payables | 11.56 Million | - | -58.95 Million | -2.44 Million | -55.63 Million | - |
| Inventory | -5.38 Million | -5.41 Million | 27.94 Million | 71.31 Million | -43.77 Million | -21.95 Million |
| Other working capital | 9.43 Million | 9.46 Million | -42.05 Million | 30.61 Million | -72.05 Million | -36.13 Million |
| Cash at beginning of period | 202.5 Million | - | 216.4 Million | 101.72 Million | 205.52 Million | - |
| Cash at end of period | 345.96 Million | 7.66 Million | 202.5 Million | 202.5 Million | 219.27 Million | 5.03 Million |
| Capital Expenditure | -13.47 Million | -13.52 Million | -137.31 Million | -64.14 Million | -71.14 Million | -13.26 Million |
| Effect of forex changes on cash | -6.28 Million | -6.31 Million | 252.32 Thousand | - | -3.58 Million | -3.65 Million |
| Net cash flow / Change in cash | 143.46 Million | 7.66 Million | -13.9 Million | 100.77 Million | 13.74 Million | 5.03 Million |
| Free Cash Flow | 26.05 Million | 26.15 Million | 11.32 Million | 233.69 Million | -222.54 Million | -89.19 Million |
CHOICEIN
301206
DKL
TKPHF
300158
BEKE